Syfovre 15 mg/.1mL
Pegcetacoplan · INJECTION, SOLUTION · Apellis Pharmaceuticals, Inc.
Syfovre is a complement inhibitor injection administered directly into the eye to treat geographic atrophy, a progressive form of age-related macular degeneration that causes vision loss. It works by blocking a part of the immune system called complement to help slow the progression of this eye disease.
Key Facts
- Brand Name
- Syfovre
- Generic Name
- Pegcetacoplan
- NDC Code (Product)
73606-020- Manufacturer
- Apellis Pharmaceuticals, Inc.
- Strength
- 15 mg/.1mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- NDA217171
- Drug Class
- Complement Inhibitor [EPC]
- Marketing Start
- 02/17/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Syfovre used for?
Syfovre is a complement inhibitor injection administered directly into the eye to treat geographic atrophy, a progressive form of age-related macular degeneration that causes vision loss. It works by blocking a part of the immune system called complement to help slow the progression of this eye disease.
Is Syfovre a controlled substance?
Syfovre is not classified as a controlled substance by the DEA.
What is the generic name for Syfovre?
The generic name for Syfovre is Pegcetacoplan. There are 1 other brand versions of Pegcetacoplan.
What is the NDC code for Syfovre 15 mg/.1mL?
The NDC (National Drug Code) for Syfovre 15 mg/.1mL is 73606-020, listed by Apellis Pharmaceuticals, Inc..